Elisa Chapuis, Elodie Bousquet, Jean-François Viallard, Benjamin Terrier, Zahir Amoura, Veronica Batani, Antoine Brézin, Patrice Cacoub, Marco Caminati, Thibaud Chazal, Cloé Comarmond, Isabelle Durieu, Mikael Ebbo, Maximilien Grall, Emmanuel Ledoult, Laura Losappio, Irene Mattioli, Arsène Mékinian, Roberto Padoan, Francesca Regola, Jan Schroeder, Lior Seluk, Ludovic Trefond, Michael E Wechsler, Guillaume Lefevre, Jean-Emmanuel Kahn, Pascal Sève, Matthieu Groh
INTRODUCTION: Eosinophils have widespread procoagulant effects. In daily practice, eosinophil-related cardiovascular toxicity consists of endomyocardial damage, eosinophilic vasculitis and arterial or venous thrombosis. Here we aim to report on the clinical features and treatment outcomes of patients with unexplained ophthalmic vascular manifestations and eosinophilia. METHODS: We conducted a retrospective, multicenter, observational study and a literature review of patients with eosinophilia (≥0...
2024: Frontiers in Immunology